American Society of Hematology/LinkedIn
Aug 30, 2026, 10:23
American Society of Hematology Updates ITP Treatment Guidelines for Adults
American Society of Hematology shared a post on LinkedIn:
“ASH has released 2026 clinical practice guidelines on initial and second-line therapy for adults with primary immune thrombocytopenia (ITP).
The guidelines include updated recommendations to support evidence-based treatment decisions and shared decision-making between clinicians and adults living with primary ITP.
Explore the guidelines and supporting resources.”
Other posts featuring American Society of Hematology on Hemostasis Today.
adult ITP
American Society of Hematology
ASH
Blood Disorders
Clinical Guidelines
Clinical Practice Guidelines
evidence-based medicine
first line therapy
Headlines
Hematology
Hematology Research
Hemostasis News
Hemostasis Today
Immune thrombocytopenia
ITP
ITP Treatment
Primary ITP
second line therapy
Shared Decision Making
thrombocytopenia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention